tirzepatide vision side effects Ozempic and other weight-loss drugs linked to rare but serious eye conditions tirzepatide and vision loss can

Early-stage clinical trials have produced unprecedented weight-loss results, eclipsing even the massive success of semaglutide ( Ozempic) and tirzepatide ( Mounjaro ), writes Hasina Kathrada for Mail & Guardian

Highlights: GLP-1 receptor drugs cause meaningful and sustained weight loss compared to placebo Industry funding raises concerns over potential bias and long-term safety gaps Independent and equitable access to these medications remains a global priority questions persist about potential biases and long-term impacts

High glucose (20 mM)-induced insulin secretion was inhibited by 1 M pasireotide treatment, comparable with the cAMP levels (Fig

Contraindications You should not use Ozempic if you or a family member has had a type of thyroid cancer called medullary thyroid carcinoma

1D, E, F and G and 2B)

Prompt consultation can prevent complications and ensure your treatment remains safe and effective